Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.

The FDA has given the green light to the first major new classes of antidepressant therapies in decades, opening up new avenues for therapeutic development.

The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.

Vesselon's microspheres optimize radiopharmaceuticals for targeted treatment, enhancing anti-tumor effects.

Bioengineered bacteria sneak past solid tumor defenses to guide CAR T cells’ attacks.

Vesselon’s novel co-formulation of gas lipid microspheres and self-assembling liposomes, targeted and activated by commercial ultrasound, would be an ideal adjunct to any of these ADC drugs.

Advanced genomic tools have provided biotech companies new approaches to help our furry friends—but experts say several limitations remain.

Renewed interest from the biotech industry sparks hope for drugging the nucleic acid to treat cancer and other conditions.

While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.
 

As medical marijuana businesses set up shop across the U.S., a handful of companies are taking the pharmaceutical route, guiding cannabis-derived drugs through clinical trials.